| 1 | tolerance induction (GO:0002507) | 9.64936478 |
| 2 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 9.40055643 |
| 3 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 8.51022089 |
| 4 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 8.48498194 |
| 5 | negative regulation of glycogen biosynthetic process (GO:0045719) | 8.40871294 |
| 6 | galactose catabolic process (GO:0019388) | 8.27680207 |
| 7 | N-terminal protein amino acid acetylation (GO:0006474) | 8.27482290 |
| 8 | regulation of oxidative stress-induced neuron death (GO:1903203) | 8.22859315 |
| 9 | interleukin-6-mediated signaling pathway (GO:0070102) | 8.13481475 |
| 10 | negative regulation of muscle hypertrophy (GO:0014741) | 7.69482011 |
| 11 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 7.64690408 |
| 12 | regulation of energy homeostasis (GO:2000505) | 7.31098139 |
| 13 | membrane tubulation (GO:0097320) | 6.81643364 |
| 14 | protein localization to endosome (GO:0036010) | 6.72814131 |
| 15 | negative regulation of glycogen metabolic process (GO:0070874) | 6.72384983 |
| 16 | cellular response to interleukin-6 (GO:0071354) | 6.53293795 |
| 17 | regulation of cellular respiration (GO:0043457) | 5.77051344 |
| 18 | ribosomal small subunit biogenesis (GO:0042274) | 5.68197887 |
| 19 | viral transcription (GO:0019083) | 5.45842080 |
| 20 | response to interleukin-6 (GO:0070741) | 5.30923488 |
| 21 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.22714254 |
| 22 | cysteine metabolic process (GO:0006534) | 5.20064494 |
| 23 | translational termination (GO:0006415) | 5.11749601 |
| 24 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.94538610 |
| 25 | galactose metabolic process (GO:0006012) | 4.63394658 |
| 26 | negative thymic T cell selection (GO:0045060) | 4.49761371 |
| 27 | forebrain morphogenesis (GO:0048853) | 4.40573142 |
| 28 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.39723531 |
| 29 | viral life cycle (GO:0019058) | 4.36885155 |
| 30 | negative T cell selection (GO:0043383) | 4.34247436 |
| 31 | N-terminal protein amino acid modification (GO:0031365) | 4.30984957 |
| 32 | protein heterotetramerization (GO:0051290) | 4.29377562 |
| 33 | sequestering of actin monomers (GO:0042989) | 4.26525232 |
| 34 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.25779608 |
| 35 | regulation of vitamin metabolic process (GO:0030656) | 4.21949922 |
| 36 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.16413562 |
| 37 | lymph node development (GO:0048535) | 4.14855340 |
| 38 | ribonucleoprotein complex biogenesis (GO:0022613) | 4.09399565 |
| 39 | megakaryocyte development (GO:0035855) | 4.08328423 |
| 40 | cotranslational protein targeting to membrane (GO:0006613) | 4.07308726 |
| 41 | response to nitrosative stress (GO:0051409) | 4.06387517 |
| 42 | ubiquinone biosynthetic process (GO:0006744) | 4.05057004 |
| 43 | protein targeting to ER (GO:0045047) | 4.02141769 |
| 44 | translational elongation (GO:0006414) | 3.99574225 |
| 45 | positive regulation of T cell apoptotic process (GO:0070234) | 3.93571074 |
| 46 | regulation of hypersensitivity (GO:0002883) | 3.91325323 |
| 47 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.82111149 |
| 48 | cellular protein complex disassembly (GO:0043624) | 3.78130513 |
| 49 | ribosome biogenesis (GO:0042254) | 3.78094387 |
| 50 | protein localization to endoplasmic reticulum (GO:0070972) | 3.71467269 |
| 51 | ribosomal large subunit biogenesis (GO:0042273) | 3.69943894 |
| 52 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.64230228 |
| 53 | negative regulation of T cell mediated immunity (GO:0002710) | 3.61663221 |
| 54 | negative regulation of potassium ion transport (GO:0043267) | 3.61326258 |
| 55 | regulation of gamma-delta T cell activation (GO:0046643) | 3.60823319 |
| 56 | ubiquinone metabolic process (GO:0006743) | 3.57336291 |
| 57 | regulation of the force of heart contraction (GO:0002026) | 3.56517996 |
| 58 | superoxide anion generation (GO:0042554) | 3.53085568 |
| 59 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.52817504 |
| 60 | regulation of mitochondrial fission (GO:0090140) | 3.49949707 |
| 61 | regulation of chromatin binding (GO:0035561) | 3.49727625 |
| 62 | negative regulation of monooxygenase activity (GO:0032769) | 3.43872009 |
| 63 | ribosomal small subunit assembly (GO:0000028) | 3.43414483 |
| 64 | positive regulation of positive chemotaxis (GO:0050927) | 3.42966965 |
| 65 | positive regulation of interleukin-12 production (GO:0032735) | 3.42464690 |
| 66 | spermatid nucleus differentiation (GO:0007289) | 3.42355423 |
| 67 | quinone biosynthetic process (GO:1901663) | 3.41707276 |
| 68 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.35263920 |
| 69 | Peyers patch development (GO:0048541) | 3.35263920 |
| 70 | chemokine-mediated signaling pathway (GO:0070098) | 3.34902203 |
| 71 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.34001923 |
| 72 | L-phenylalanine catabolic process (GO:0006559) | 3.34001923 |
| 73 | cytokine secretion (GO:0050663) | 3.29962024 |
| 74 | regulation of positive chemotaxis (GO:0050926) | 3.29706658 |
| 75 | mast cell activation (GO:0045576) | 3.28368089 |
| 76 | tyrosine metabolic process (GO:0006570) | 3.26797518 |
| 77 | valine metabolic process (GO:0006573) | 3.21490179 |
| 78 | mRNA modification (GO:0016556) | 3.18887208 |
| 79 | regulation of cardiac muscle hypertrophy (GO:0010611) | 3.18543612 |
| 80 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.16590231 |
| 81 | protein complex disassembly (GO:0043241) | 3.12105008 |
| 82 | thymic T cell selection (GO:0045061) | 3.11513088 |
| 83 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 3.08073178 |
| 84 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 3.08073178 |
| 85 | regulation of muscle hypertrophy (GO:0014743) | 3.08065008 |
| 86 | negative regulation of cell killing (GO:0031342) | 3.07892968 |
| 87 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.07892968 |
| 88 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.03974360 |
| 89 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.03459381 |
| 90 | negative regulation of T cell differentiation in thymus (GO:0033085) | 3.02984971 |
| 91 | erythrocyte maturation (GO:0043249) | 3.02916045 |
| 92 | regulation of mitochondrial depolarization (GO:0051900) | 3.01182061 |
| 93 | regulation of respiratory gaseous exchange (GO:0043576) | 3.00076388 |
| 94 | endoderm formation (GO:0001706) | 3.00047189 |
| 95 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.97822055 |
| 96 | interkinetic nuclear migration (GO:0022027) | 2.95907503 |
| 97 | regulation of interleukin-12 production (GO:0032655) | 2.91204388 |
| 98 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.88986290 |
| 99 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.88986290 |
| 100 | respiratory chain complex IV assembly (GO:0008535) | 2.88438858 |
TRAV36DV7 
